These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31409515)

  • 1. High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion.
    Santovito D; Marcantonio P; Mastroiacovo D; Natarelli L; Mandolini C; De Nardis V; Paganelli C; De Cesare D; Affaitati G; Giamberardino MA; Stellin L; Pinelli M; Weber C; De Blasis G; Occhiuzzi U; Bucci M; Desideri G; Cipollone F
    Int J Cardiol; 2020 Jan; 299():249-253. PubMed ID: 31409515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of microRNAs 758 and 33b as potential modulators of ABCA1 expression in human atherosclerotic plaques.
    Mandolini C; Santovito D; Marcantonio P; Buttitta F; Bucci M; Ucchino S; Mezzetti A; Cipollone F
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):202-9. PubMed ID: 25445880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment.
    Frambach SJCM; de Haas R; Smeitink JAM; Rongen GA; Russel FGM; Schirris TJJ
    Pharmacol Rev; 2020 Jan; 72(1):152-190. PubMed ID: 31831519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1/G1 in macrophages.
    Yang S; Ye ZM; Chen S; Luo XY; Chen SL; Mao L; Li Y; Jin H; Yu C; Xiang FX; Xie MX; Chang J; Xia YP; Hu B
    J Mol Cell Cardiol; 2018 Oct; 123():139-149. PubMed ID: 30227118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.
    Niesor EJ; Schwartz GG; Perez A; Stauffer A; Durrwell A; Bucklar-Suchankova G; Benghozi R; Abt M; Kallend D
    Cardiovasc Drugs Ther; 2015 Feb; 29(1):7-14. PubMed ID: 25749868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.
    Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2011 Aug; 43(9):619-24. PubMed ID: 21823057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin.
    Otake H; Sugizaki Y; Toba T; Nagano Y; Tsukiyama Y; Yanaka KI; Yamamoto H; Nagasawa A; Onishi H; Takeshige R; Nakano S; Matsuoka Y; Tanimura K; Kawamori H; Shinke T; Hirata KI
    J Cardiol; 2019 Mar; 73(3):228-232. PubMed ID: 30579806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells.
    Genvigir FD; Rodrigues AC; Cerda A; Hirata MH; Curi R; Hirata RD
    Drug Metabol Drug Interact; 2011; 26(1):33-6. PubMed ID: 21417795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
    Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
    Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages.
    Zeng Y; Peng Y; Tang K; Wang YQ; Zhao ZY; Wei XY; Xu XL
    Biomed Pharmacother; 2018 May; 101():543-552. PubMed ID: 29505925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.
    Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff MJ; Ronda N
    J Transl Autoimmun; 2023 Dec; 7():100206. PubMed ID: 37484708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib.
    Nicholls SJ; Ruotolo G; Brewer HB; Kane JP; Wang MD; Krueger KA; Adelman SJ; Nissen SE; Rader DJ
    J Am Coll Cardiol; 2015 Nov; 66(20):2201-2210. PubMed ID: 26564598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.
    Ma X; Li SF; Qin ZS; Ye J; Zhao ZL; Fang HH; Yao ZW; Gu MN; Hu YW
    Cardiovasc Pathol; 2015; 24(4):230-5. PubMed ID: 25600616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
    Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
    Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins.
    Chen WM; Sheu WH; Tseng PC; Lee TS; Lee WJ; Chang PJ; Chiang AN
    PLoS One; 2016; 11(5):e0154672. PubMed ID: 27139226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
    Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
    Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
    Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M
    Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Water- and Lipid-Soluble Statins on Nonculprit Lesions in Patients with Acute Coronary Syndrome.
    Ishikawa Y; Itoh T; Satoh M; Fusazaki T; Sugawara S; Nakajima S; Nakamura M; Morino Y
    Int Heart J; 2018 Jan; 59(1):27-34. PubMed ID: 29279527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway.
    Zhao ZW; Zhang M; Chen LY; Gong D; Xia XD; Yu XH; Wang SQ; Ou X; Dai XY; Zheng XL; Zhang DW; Tang CK
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):806-822. PubMed ID: 29678642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.